Retail investor chatter around vaccine makers Novavax, Moderna, and Pfizer rose on Wednesday, ahead of a closely watched CDC ...

The meeting, scheduled for June 25-26, will review existing data and vote on RSV and influenza vaccines, along with ...

We came across a bullish thesis on Moderna, Inc. (MRNA) on Natan’s Substack. In this article, we will summarize the bulls’ ...

Experts fear a hyper virulent new strain of the virus, dubbed 'Nimbus', could drive a wave of cases this summer, with recent ...

A highly contagious Covid variant is on the rise in the UK, with official data suggesting rates have doubled in a month.

The Moderna vaccine can be efficient at protecting individuals and people around them from COVID-19. Learn more about it here.

Moderna says it has become the first company in the pharma sector with phase 3 data on a combined vaccine for both COVID-19 and influenza. Skip to main content Friday 20 June 2025 . BlueSky ...

Moderna's new version of its COVID-19 vaccine, which targets two virus variants including Omicron, has outperformed the company's original Spikevax shot in a head-to-head clinical trial. mRNA-1273 ...